BIOVET ApS: Financial statements 2025
CVR: 13228787
Source: annual report 2025, Danish Business Authority
01/05/2024 – 30/04/2025
BIOVET ApS (CVR 13228787) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 6,877,363 and a net result of DKK 5,093,047 compared with DKK 33,296,159 the year before. That is an increase of 49.4% compared with the year before. Equity in the 2025 report amounted to DKK 78,374,670. The solvency ratio was 85.7%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 6,877,363
- Profit/Loss
- DKK 5,093,047
- Equity
- DKK 78,374,670
- Total Assets
- DKK 91,438,657
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 6.9M | 5.1M | 78.4M | 1 |
| 2024 | - | 4.6M | 33.3M | 235.4M | 1 |
| 2023 | - | 3.7M | 94.8M | 202.1M | 1 |
| 2022 | - | 4.5M | 9.8M | 107.4M | 1 |
| 2021 | - | 10.8M | 3.8M | 97.6M | 1 |
Official annual report
How creditworthy is BIOVET ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout BIOVET ApS
BIOVET ApS is a Danish company of the type Anpartsselskab based in Fredensborg, founded in 1989. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ApS SPKR 4 NR. 2590. The management consists of Thomas Velin and Flemming Velin. The company is owned by NORDVET ApS. The company has 1 employee (2026). In 2026, the company reported a gross profit of DKK 840,557 and a net result of DKK 13,714,147 compared with DKK 5,093,047 the year before. Equity in the 2026 report amounted to DKK 75,088,817.